A Randomized, Double Blind, Multicentric, Placebo Controlled, Single Dose, Phase - i/ii Study Assessing the Safety and Efficacy of Intramuscular ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With Critical Limb Ischemia (Cli)
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Chronic limb-threatening ischemia
- Focus Adverse reactions
- Sponsors Stempeutics
- 10 Jun 2014 New trial record